NEET-UG previous year question
In gene therapy of Adenosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:
Asked in NEET (UG) 2022 · 160 Qs · Zoology
Tap an option to check your answer.
Show answer and explanation
Correct answer: (D) Genetically engineered lymphocytes are not immortal cells.
In ADA gene therapy, lymphocytes are taken from the patient, grown in culture, given a working ADA gene with a retroviral vector, and returned to the body.
These lymphocytes have a limited lifespan; they are not immortal. As they die, ADA activity is lost, so the patient needs periodic infusions. A permanent cure would need the gene put into bone-marrow stem cells or at the embryonic stage. The answer is option (D).
More solved Zoology questions
- Natural selection where more individuals acquire specific character value other than the mean character value, leads to
- Which of the following is not the function of conducting part of respiratory system?
- At which stage of life the oogenesis process is initiated?
- Select the incorrect statement with respect to acquired immunity.
- Which one of the following statements is correct?
- Match List-I with List-II: List - I (Biological Molecules) List - II (Biological functions) (a) Glycogen (i) Hormone (b) Globulin (ii)…